The global Neprilysin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Neprilysin production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Neprilysin by regions (countries) and by Application.
The global Neprilysin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Neprilysin market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Neprilysin markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Neprilysin market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Neprilysin market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Neprilysin market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Neprilysin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Neprilysin market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Neprilysin market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Neprilysin market by each application segment for the same period.
This report includes the following manufacturers:
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Market Segment by Type
TD-0714
STR-324
PL-265
LHW-090
Others
Market Segment by Application
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
Research Methodology
To compile the detailed study of the global Neprilysin market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Neprilysin market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Neprilysin market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Neprilysin production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Neprilysin by regions (countries) and by Application.
The global Neprilysin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Neprilysin market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Neprilysin markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Neprilysin market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Neprilysin market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Neprilysin market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Neprilysin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Neprilysin market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Neprilysin market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Neprilysin market by each application segment for the same period.
This report includes the following manufacturers:
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
Market Segment by Type
TD-0714
STR-324
PL-265
LHW-090
Others
Market Segment by Application
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
Research Methodology
To compile the detailed study of the global Neprilysin market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Neprilysin market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Neprilysin market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Neprilysin Market Size Growth Rate by Type
1.2.2 TD-0714
1.2.3 STR-324
1.2.4 PL-265
1.2.5 LHW-090
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Neprilysin Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Acute Heart Failure
1.3.3 Cancer Pain
1.3.4 Hypertension
1.3.5 Alzheimer's Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Neprilysin Market Size (2016-2027)
2.1.1 Global Neprilysin Revenue (2016-2027)
2.1.2 Global Neprilysin Sales (2016-2027)
2.2 Global Neprilysin Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Neprilysin Sales by Regions (2016-2021)
2.2.2 Global Neprilysin Revenue by Regions (2016-2021)
2.3 Global Neprilysin Market Size Forecast by Region
2.3.1 Global Neprilysin Sales Forecast by Region (2022-2027)
2.3.2 Global Neprilysin Revenue Forecast by Region (2022-2027)
2.4 Global Top Neprilysin Regions (Countries) Ranking by Market Size
2.5 Neprilysin Industry Trends
2.5.1 Neprilysin Market Trends
2.5.2 Neprilysin Market Drivers
2.5.3 Neprilysin Market Challenges
2.5.4 Neprilysin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Neprilysin Manufacturers by Sales (2016-2021)
3.1.1 Global Neprilysin Sales by Manufacturers (2016-2021)
3.1.2 Global Neprilysin Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Neprilysin Sales in 2020
3.2 Global Top Manufacturers Neprilysin by Revenue
3.2.1 Global Neprilysin Revenue by Manufacturers (2016-2021)
3.2.2 Top Neprilysin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Neprilysin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Neprilysin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neprilysin as of 2020)
3.4 Global Neprilysin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Neprilysin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Neprilysin Market
3.7 Key Manufacturers Neprilysin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Neprilysin Market Size by Type
4.1 Global Neprilysin Historic Market Review by Type (2016-2021)
4.1.1 Global Neprilysin Sales Market Share by Type (2016-2021)
4.1.2 Global Neprilysin Revenue Market Share by Type (2016-2021)
4.1.3 Neprilysin Price by Type (2016-2021)
4.2 Global Neprilysin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neprilysin Sales Forecast by Type (2022-2027)
4.2.2 Global Neprilysin Revenue Forecast by Type (2022-2027)
4.2.3 Neprilysin Price Forecast by Type (2022-2027)
5 Global Neprilysin Market Size by Application
5.1 Global Neprilysin Historic Market Review by Application (2016-2021)
5.1.1 Global Neprilysin Sales Market Share by Application (2016-2021)
5.1.2 Global Neprilysin Revenue Market Share by Application (2016-2021)
5.1.3 Neprilysin Price by Application (2016-2021)
5.2 Global Neprilysin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neprilysin Sales Forecast by Application (2022-2027)
5.2.2 Global Neprilysin Revenue Forecast by Application (2022-2027)
5.2.3 Neprilysin Price Forecast by Application (2022-2027)
6 North America
6.1 North America Neprilysin Sales Breakdown by Company
6.1.1 North America Neprilysin Sales by Company (2016-2027)
6.1.2 North America Neprilysin Revenue by Company (2016-2027)
6.2 North America Neprilysin Market Size by Type (2016-2027)
6.2.1 North America Neprilysin Sales by Type (2016-2027)
6.2.2 North America Neprilysin Revenue by Type (2016-2027)
6.3 North America Neprilysin Market Size by Application (2016-2027)
6.3.1 North America Neprilysin Sales by Application (2016-2027)
6.3.2 North America Neprilysin Revenue by Application (2016-2027)
6.4 North America Neprilysin Market Size by Country
6.4.1 North America Neprilysin Sales by Country (2016-2027)
6.4.2 North America Neprilysin Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neprilysin Sales Breakdown by Company
7.1.1 Europe Neprilysin Sales by Company (2016-2027)
7.1.2 Europe Neprilysin Revenue by Company (2016-2027)
7.2 Europe Neprilysin Market Size by Type (2016-2027)
7.2.1 Europe Neprilysin Sales by Type (2016-2027)
7.2.2 Europe Neprilysin Revenue by Type (2016-2027)
7.3 Europe Neprilysin Market Size by Application (2016-2027)
7.3.1 Europe Neprilysin Sales by Application (2016-2027)
7.3.2 Europe Neprilysin Revenue by Application (2016-2027)
7.4 Europe Neprilysin Market Size by Country
7.4.1 Europe Neprilysin Sales by Country (2016-2027)
7.4.2 Europe Neprilysin Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neprilysin Sales Breakdown by Company
8.1.1 Asia Pacific Neprilysin Sales by Company (2016-2027)
8.1.2 Asia Pacific Neprilysin Revenue by Company (2016-2027)
8.2 Asia Pacific Neprilysin Market Size by Type (2016-2027)
8.2.1 Asia Pacific Neprilysin Sales by Type (2016-2027)
8.2.2 Asia Pacific Neprilysin Revenue by Type (2016-2027)
8.3 Asia Pacific Neprilysin Market Size by Application (2016-2027)
8.3.1 Asia Pacific Neprilysin Sales by Application (2016-2027)
8.3.2 Asia Pacific Neprilysin Revenue by Application (2016-2027)
8.4 Asia Pacific Neprilysin Market Size by Regions
8.4.1 Asia Pacific Neprilysin Sales by Regions
8.4.2 Asia Pacific Neprilysin Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Neprilysin Sales Breakdown by Company
9.1.1 Latin America Neprilysin Sales by Company (2016-2027)
9.1.2 Latin America Neprilysin Revenue by Company (2016-2027)
9.2 Latin America Neprilysin Market Size by Type (2016-2027)
9.2.1 Latin America Neprilysin Sales by Type (2016-2027)
9.2.2 Latin America Neprilysin Revenue by Type (2016-2027)
9.3 Latin America Neprilysin Market Size by Application (2016-2027)
9.3.1 Latin America Neprilysin Sales by Application (2016-2027)
9.3.2 Latin America Neprilysin Revenue by Application (2016-2027)
9.4 Latin America Neprilysin Market Size by Country
9.4.1 Latin America Neprilysin Sales by Country (2016-2027)
9.4.2 Latin America Neprilysin Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neprilysin Sales Breakdown by Company
10.1.1 Middle East and Africa Neprilysin Sales by Company (2016-2027)
10.1.2 Middle East and Africa Neprilysin Revenue by Company (2016-2027)
10.2 Middle East and Africa Neprilysin Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Neprilysin Sales by Type (2016-2027)
10.2.2 Middle East and Africa Neprilysin Revenue by Type (2016-2027)
10.3 Middle East and Africa Neprilysin Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Neprilysin Sales by Application (2016-2027)
10.3.2 Middle East and Africa Neprilysin Revenue by Application (2016-2027)
10.4 Middle East and Africa Neprilysin Market Size by Country
10.4.1 Middle East and Africa Neprilysin Sales by Country (2016-2027)
10.4.2 Middle East and Africa Neprilysin Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Corporation Information
11.1.2 Bioprojet SCR Overview
11.1.3 Bioprojet SCR Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Bioprojet SCR Neprilysin Products and Services
11.1.5 Bioprojet SCR Neprilysin SWOT Analysis
11.1.6 Bioprojet SCR Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Novartis AG Neprilysin Products and Services
11.2.5 Novartis AG Neprilysin SWOT Analysis
11.2.6 Novartis AG Recent Developments
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Corporation Information
11.3.2 Pharmaleads SA Overview
11.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Pharmaleads SA Neprilysin Products and Services
11.3.5 Pharmaleads SA Neprilysin SWOT Analysis
11.3.6 Pharmaleads SA Recent Developments
11.4 Theravance Biopharma Inc
11.4.1 Theravance Biopharma Inc Corporation Information
11.4.2 Theravance Biopharma Inc Overview
11.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Theravance Biopharma Inc Neprilysin Products and Services
11.4.5 Theravance Biopharma Inc Neprilysin SWOT Analysis
11.4.6 Theravance Biopharma Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Neprilysin Value Chain Analysis
12.2 Neprilysin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neprilysin Production Mode & Process
12.4 Neprilysin Sales and Marketing
12.4.1 Neprilysin Sales Channels
12.4.2 Neprilysin Distributors
12.5 Neprilysin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Neprilysin Market Size Growth Rate by Type
1.2.2 TD-0714
1.2.3 STR-324
1.2.4 PL-265
1.2.5 LHW-090
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Neprilysin Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Acute Heart Failure
1.3.3 Cancer Pain
1.3.4 Hypertension
1.3.5 Alzheimer's Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Neprilysin Market Size (2016-2027)
2.1.1 Global Neprilysin Revenue (2016-2027)
2.1.2 Global Neprilysin Sales (2016-2027)
2.2 Global Neprilysin Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Neprilysin Sales by Regions (2016-2021)
2.2.2 Global Neprilysin Revenue by Regions (2016-2021)
2.3 Global Neprilysin Market Size Forecast by Region
2.3.1 Global Neprilysin Sales Forecast by Region (2022-2027)
2.3.2 Global Neprilysin Revenue Forecast by Region (2022-2027)
2.4 Global Top Neprilysin Regions (Countries) Ranking by Market Size
2.5 Neprilysin Industry Trends
2.5.1 Neprilysin Market Trends
2.5.2 Neprilysin Market Drivers
2.5.3 Neprilysin Market Challenges
2.5.4 Neprilysin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Neprilysin Manufacturers by Sales (2016-2021)
3.1.1 Global Neprilysin Sales by Manufacturers (2016-2021)
3.1.2 Global Neprilysin Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Neprilysin Sales in 2020
3.2 Global Top Manufacturers Neprilysin by Revenue
3.2.1 Global Neprilysin Revenue by Manufacturers (2016-2021)
3.2.2 Top Neprilysin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Neprilysin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Neprilysin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neprilysin as of 2020)
3.4 Global Neprilysin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Neprilysin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Neprilysin Market
3.7 Key Manufacturers Neprilysin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Neprilysin Market Size by Type
4.1 Global Neprilysin Historic Market Review by Type (2016-2021)
4.1.1 Global Neprilysin Sales Market Share by Type (2016-2021)
4.1.2 Global Neprilysin Revenue Market Share by Type (2016-2021)
4.1.3 Neprilysin Price by Type (2016-2021)
4.2 Global Neprilysin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neprilysin Sales Forecast by Type (2022-2027)
4.2.2 Global Neprilysin Revenue Forecast by Type (2022-2027)
4.2.3 Neprilysin Price Forecast by Type (2022-2027)
5 Global Neprilysin Market Size by Application
5.1 Global Neprilysin Historic Market Review by Application (2016-2021)
5.1.1 Global Neprilysin Sales Market Share by Application (2016-2021)
5.1.2 Global Neprilysin Revenue Market Share by Application (2016-2021)
5.1.3 Neprilysin Price by Application (2016-2021)
5.2 Global Neprilysin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neprilysin Sales Forecast by Application (2022-2027)
5.2.2 Global Neprilysin Revenue Forecast by Application (2022-2027)
5.2.3 Neprilysin Price Forecast by Application (2022-2027)
6 North America
6.1 North America Neprilysin Sales Breakdown by Company
6.1.1 North America Neprilysin Sales by Company (2016-2027)
6.1.2 North America Neprilysin Revenue by Company (2016-2027)
6.2 North America Neprilysin Market Size by Type (2016-2027)
6.2.1 North America Neprilysin Sales by Type (2016-2027)
6.2.2 North America Neprilysin Revenue by Type (2016-2027)
6.3 North America Neprilysin Market Size by Application (2016-2027)
6.3.1 North America Neprilysin Sales by Application (2016-2027)
6.3.2 North America Neprilysin Revenue by Application (2016-2027)
6.4 North America Neprilysin Market Size by Country
6.4.1 North America Neprilysin Sales by Country (2016-2027)
6.4.2 North America Neprilysin Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Neprilysin Sales Breakdown by Company
7.1.1 Europe Neprilysin Sales by Company (2016-2027)
7.1.2 Europe Neprilysin Revenue by Company (2016-2027)
7.2 Europe Neprilysin Market Size by Type (2016-2027)
7.2.1 Europe Neprilysin Sales by Type (2016-2027)
7.2.2 Europe Neprilysin Revenue by Type (2016-2027)
7.3 Europe Neprilysin Market Size by Application (2016-2027)
7.3.1 Europe Neprilysin Sales by Application (2016-2027)
7.3.2 Europe Neprilysin Revenue by Application (2016-2027)
7.4 Europe Neprilysin Market Size by Country
7.4.1 Europe Neprilysin Sales by Country (2016-2027)
7.4.2 Europe Neprilysin Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neprilysin Sales Breakdown by Company
8.1.1 Asia Pacific Neprilysin Sales by Company (2016-2027)
8.1.2 Asia Pacific Neprilysin Revenue by Company (2016-2027)
8.2 Asia Pacific Neprilysin Market Size by Type (2016-2027)
8.2.1 Asia Pacific Neprilysin Sales by Type (2016-2027)
8.2.2 Asia Pacific Neprilysin Revenue by Type (2016-2027)
8.3 Asia Pacific Neprilysin Market Size by Application (2016-2027)
8.3.1 Asia Pacific Neprilysin Sales by Application (2016-2027)
8.3.2 Asia Pacific Neprilysin Revenue by Application (2016-2027)
8.4 Asia Pacific Neprilysin Market Size by Regions
8.4.1 Asia Pacific Neprilysin Sales by Regions
8.4.2 Asia Pacific Neprilysin Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Neprilysin Sales Breakdown by Company
9.1.1 Latin America Neprilysin Sales by Company (2016-2027)
9.1.2 Latin America Neprilysin Revenue by Company (2016-2027)
9.2 Latin America Neprilysin Market Size by Type (2016-2027)
9.2.1 Latin America Neprilysin Sales by Type (2016-2027)
9.2.2 Latin America Neprilysin Revenue by Type (2016-2027)
9.3 Latin America Neprilysin Market Size by Application (2016-2027)
9.3.1 Latin America Neprilysin Sales by Application (2016-2027)
9.3.2 Latin America Neprilysin Revenue by Application (2016-2027)
9.4 Latin America Neprilysin Market Size by Country
9.4.1 Latin America Neprilysin Sales by Country (2016-2027)
9.4.2 Latin America Neprilysin Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Neprilysin Sales Breakdown by Company
10.1.1 Middle East and Africa Neprilysin Sales by Company (2016-2027)
10.1.2 Middle East and Africa Neprilysin Revenue by Company (2016-2027)
10.2 Middle East and Africa Neprilysin Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Neprilysin Sales by Type (2016-2027)
10.2.2 Middle East and Africa Neprilysin Revenue by Type (2016-2027)
10.3 Middle East and Africa Neprilysin Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Neprilysin Sales by Application (2016-2027)
10.3.2 Middle East and Africa Neprilysin Revenue by Application (2016-2027)
10.4 Middle East and Africa Neprilysin Market Size by Country
10.4.1 Middle East and Africa Neprilysin Sales by Country (2016-2027)
10.4.2 Middle East and Africa Neprilysin Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Bioprojet SCR
11.1.1 Bioprojet SCR Corporation Information
11.1.2 Bioprojet SCR Overview
11.1.3 Bioprojet SCR Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Bioprojet SCR Neprilysin Products and Services
11.1.5 Bioprojet SCR Neprilysin SWOT Analysis
11.1.6 Bioprojet SCR Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Novartis AG Neprilysin Products and Services
11.2.5 Novartis AG Neprilysin SWOT Analysis
11.2.6 Novartis AG Recent Developments
11.3 Pharmaleads SA
11.3.1 Pharmaleads SA Corporation Information
11.3.2 Pharmaleads SA Overview
11.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Pharmaleads SA Neprilysin Products and Services
11.3.5 Pharmaleads SA Neprilysin SWOT Analysis
11.3.6 Pharmaleads SA Recent Developments
11.4 Theravance Biopharma Inc
11.4.1 Theravance Biopharma Inc Corporation Information
11.4.2 Theravance Biopharma Inc Overview
11.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Theravance Biopharma Inc Neprilysin Products and Services
11.4.5 Theravance Biopharma Inc Neprilysin SWOT Analysis
11.4.6 Theravance Biopharma Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Neprilysin Value Chain Analysis
12.2 Neprilysin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neprilysin Production Mode & Process
12.4 Neprilysin Sales and Marketing
12.4.1 Neprilysin Sales Channels
12.4.2 Neprilysin Distributors
12.5 Neprilysin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
